Bone metastases

Traditionally, patients with bone metastases (spread of cancer to bone) have not qualified to participate in clinical trials of new therapeutics because it was not possible to evaluate the response of their disease accurately.

We have developed new methods for monitoring tumour growth and treatment effect in bone and use this information to predict fracture risk.

Ongoing research activities

• Developing local minimally invasive targeted treatments for non-responsive tumours in bone
• Evaluating markers that may indicate and direct best treatments both for the cancer and the remaining bone